|
1
|
Duncan BW, Bohn DJ, Atz AM, French JW,
Laussen PC and Wessel DL: Mechanical circulatory support for the
treatment of children with acute fulminant myocarditis. J Thorac
Cardiovasc Surg. 122:440–448. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Woodruff JF: Viral myocarditis. A review.
Am J Pathol. 101:425–484. 1980.PubMed/NCBI
|
|
3
|
Bowles NE, Richardson PJ, Olsen EG and
Archard LC: Detection of Coxsackie-B-virus-specific RNA sequences
in myocardial biopsy samples from patients with myocarditis and
dilated cardiomyopathy. Lancet. 1:1120–1123. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kandolf R, Klingel K, Mertsching H, et al:
Molecular studies on enteroviral heart disease: patterns of acute
and persistent infections. Eur Heart J. 12(Suppl D): 49–55. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morimoto S, Hiramitsu S, Yamada K, et al:
Clinical and pathologic features of chronic myocarditis: four
autopsy cases presenting as dilated cardiomyopathy in life. Am J
Cardiovasc Pathol. 4:181–191. 1992.PubMed/NCBI
|
|
6
|
Maier R, Krebs P and Ludewig B:
Immunopathological basis of virus-induced myocarditis. Clin Dev
Immunol. 11:1–5. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shauer A, Gotsman I, Keren A, et al: Acute
viral myocarditis: current concepts in diagnosis and treatment. Isr
Med Assoc J. 15:180–185. 2013.PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Rosa S, Curcio A and Indolfi C:
Emerging role of microRNAs in cardiovascular diseases. Circ J.
78:567–575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Corsten MF, Papageorgiou A, Verhesen W, et
al: MicroRNA profiling identifies microRNA-155 as an adverse
mediator of cardiac injury and dysfunction during acute viral
myocarditis. Circ Res. 111:415–425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maes OC, Chertkow HM, Wang E and Schipper
HM: MicroRNA: implications for alzheimer disease and other human
CNS disorders. Curr Genomics. 10:154–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu J, Li Y, Wang F, et al: Suppressed
miR-424 expression via upregulation of target gene Chk1 contributes
to the progression of cervical cancer. Oncogene. 32:976–987. 2013.
View Article : Google Scholar
|
|
13
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20.
2013.PubMed/NCBI
|
|
14
|
Corsten MF, Dennert R, Jochems S, et al:
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial
damage in cardiovascular disease. Circ Cardiovasc Genet. 3:499–506.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen Y, Xu W, Chu YW, Wang Y, Liu QS and
Xiong SD: Coxsackievirus group B type 3 infection upregulates
expression of monocyte chemoattractant protein 1 in cardiac
myocytes, which leads to enhanced migration of mononuclear cells in
viral myocarditis. J Virol. 78:12548–12556. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu YL, Wu W, Xue Y, et al: MicroRNA-21
and -146b are involved in the pathogenesis of murine viral
myocarditis by regulating TH-17 differentiation. Arch Virol.
158:1953–1963. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tijsen AJ, Pinto YM and Creemers EE:
Circulating microRNAs as diagnostic biomarkers for cardiovascular
diseases. Am J Physiol Heart Circ Physiol. 303:H1085–H1095. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thompson JD, Gibson TJ, Plewniak F,
Jeanmougin F and Higgins DG: The CLUSTAL_X windows interface:
Flexible strategies for multiple sequence alignment aided by
quality analysis tools. Nucleic Acids Res. 25:4876–4882. 1997.
View Article : Google Scholar
|
|
20
|
Esfandiarei M and McManus BM: Molecular
biology and pathogenesis of viral myocarditis. Annu Rev Pathol.
3:127–155. 2008. View Article : Google Scholar
|
|
21
|
Klingel K and Kandolf R: The role of
enterovirus replication in the development of acute and chronic
heart muscle disease in different immunocompetent mouse strains.
Scand J Infect Dis Suppl. 88:79–85. 1993.PubMed/NCBI
|
|
22
|
Fuse K, Chan G, Liu Y, et al: Myeloid
differentiation factor-88 plays a crucial role in the pathogenesis
of Coxsackievirus B3-induced myocarditis and influences type I
interferon production. Circulation. 112:2276–2285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leipner C, Grün K, Borchers M and Stelzner
A: The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is
influenced by the cellular immune status. Herz. 25:245–248. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Calabrese F and Thiene G: Myocarditis and
inflammatory cardiomyopathy: microbiological and molecular
biological aspects. Cardiovasc Res. 60:11–25. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matsumori A, Yamada T, Suzuki H, Matoba Y
and Sasayama S: Increased circulating cytokines in patients with
myocarditis and cardiomyopathy. Br Heart J. 72:561–566. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levine B, Kalman J, Mayer L, Fillit HM and
Packer M: Elevated circulating levels of tumor necrosis factor in
severe chronic heart failure. N Engl J Med. 323:236–241. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schultz JC, Hilliard AA, Cooper LT Jr and
Rihal CS: Diagnosis and treatment of viral myocarditis. Mayo Clin
Proc. 84:1001–1009. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu HF, Ding YJ, Shen YW, et al: MicroRNA-1
represses Cx43 expression in viral myocarditis. Mol Cell Biochem.
362:141–148. 2012. View Article : Google Scholar
|
|
29
|
Hemida MG, Ye X, Zhang HM, et al:
MicroRNA-203 enhances coxsackievirus B3 replication through
targeting zinc finger protein-148. Cell Mol Life Sci. 70:277–291.
2013. View Article : Google Scholar
|
